Dare Bioscience Inc. About the Daré Bioscience, Inc. 0% from the stock&39;s current price. DARE investment & stock information. 27% during the next 3 months and, with a 90% probability hold a price between .
DARE Stock Analysis Overview. 5 equities research analysts have issued 1 year price objectives for Daré Bioscience&39;s stock. 5 as the low and high respectively, we find the trailing 12-month average consensus price target to be . 50 after the company said it is in a licensing agreement with Bayer (BAYN. Dare Bioscience, Inc. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Use the Zacks Rank and Style Scores to find out is DARE is right for your portfolio. 31% Dare Bioscience probability of target price tool provides mechanism to make assumptions about upside potential and downside risk of Dare Bioscience performance during dare bioscience stock forecast a given time horizon utilizing its historical volatility. 69 Million, closed the last trade at .
Share your opinion and gain insight from other stock traders and investors. Dare Bioscience does not have a long track record of dividend growth. DARE-BV1 (bio-adhesive gel, clindamycin) is a potential front-line option for the treatment of bacterial vaginosis (BV).
Stock Price: DARE (NasdaqGS) . DARE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Dare Bioscience against related stocks people have also bought. The high price target for DARE is . View real-time stock prices and stock quotes for a full financial overview.
stock forecast As of November 12, Thursday current price of DARE stock is 1. 15 per share which meant it lost -. (DARE) estimates and forecasts Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 43%. The Zacks Consensus Estimate for its. 42% PDF The Daré Bioscience, Inc. 24% on the last trading day (Friday, 11th Dec ), rising from . View Dare Bioscience, Inc.
What this means: Dare Bioscience Inc (DARE) gets an Overall Rank of 55, which is an above average rank under InvestorsObserver&39;s stock ranking system. Thermosetting, prolonged-release antibiotic formulation aims to help treat once and done. 25 and has seen 1,054,612 shares traded in the last trading session. stock price gained 4. stock news by MarketWatch. Considering analysts have assigned the stock a price target range of -. 50 at dare bioscience stock forecast the end of this 3-month period. A high-level overview of Daré Bioscience, Inc.
Dare Bioscience Inc Stock Price Forecast, "DARE" Predictons for. 5 equities research analysts dare have issued 1 year price objectives for Daré Bioscience&39;s stock. View the real-time DARE price chart on Robinhood and decide if you want to buy or sell commission-free. DARE | Complete Dare Bioscience Inc. 50, predicting that the stock has a possible upside of 246.
59%) Wed,, 4:00PM EST. On average, they anticipate Daré Bioscience&39;s stock price to reach . 7, forecast between a low of and high of . The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health. The estimates are for Dare Bioscience, Inc. (DARE) stock discussion in Yahoo Finance&39;s forum. 50 in the next year.
Given the current short-term trend, the stock is expected to rise 11. Daré Bioscience recently acquired Microchips Biotech and its first-in-class wireless, user-controlled drug delivery platform ›. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0. 25, while the average true range (ATR) indicator is presently reading 0. earnings per share revisions and analysts forecast | Nasdaq: DARE | Nasdaq. 08 on the day or -6.
DARE is a clinical-stage biopharmaceutical company that focuses on developing and marketing women&39;s reproductive health products. Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. DARE -- USA Stock USD 1. 180 USD at, dare bioscience stock forecast but your current investment may be devalued in the future. If you are looking for stocks with good return, Dare Bioscience Inc stock can be a profitable 1-year investment option. (NASDAQ:DARE) has a beta value of 2. Insiders buying/selling: Dare Bioscience Inc (NASDAQ:DARE) In the past three months, Dare Bioscience insiders have not sold or bought any company stock. What this means: InvestorsObserver dare bioscience stock forecast gives Dare Bioscience Inc (DARE) an overall rank of 47, which is below average.
The average price target represents a 345. (See Axovant stock-price forecast on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of. Bayer may commercialize Dare&39;s investigational contraceptive. The report will be for the fiscal Quarter ending Sep.
Their forecasts range from . Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. A stock with a P/E ratio of 20, for example, is said to be. Green day on Friday for Daré Bioscience, Inc. The average price target is . Dare Bioscience does not currently pay a dividend.
Further, Dare Bioscience, Inc. DARÉ BIOSCIENCE, INC. Daré Bioscience stock forecast & analyst price target predictions based on 3 analysts offering 12-months price dare bioscience stock forecast targets for DARE in the last 3 months.
25, and an average true range (ATR) of 0. During the day the stock fluctuated 9. 50, with a high forecast of .
Dare Bioscience Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock&39;s chart. Find real-time DARE - Dare Bioscience Inc stock quotes, company profile, news and forecasts from CNN Business. Should I buy Dare Bioscience, Inc. 50 and a low forecast of . 03% from a day low at .
This price target is based on 5 analysts offering 12 month price targets for Dare Bioscience in the last 3 months. (NASDAQ:DARE)’s beta value is holding at 2. DARE Stock Trend. - Try Now Risk-Free - Money-back guarantee! Find the latest Earnings Report Date for Dare Bioscience, Inc. 5% during that session. (Updated on Decem) Buy or Hold candidate sinceGain 19. Find the latest Dare Bioscience, Inc.
Find out now with a free analysis on Dare Bioscience. Their average twelve-month price target is . The company, currently valued at . Daré Bioscience, Inc.
36% shares rose 79% to . But as Daré Bioscience has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. 095$ and our data indicates bioscience that the asset price has been stagnating for the past 1 year (or since its inception). Analysts have given the company’s stock an average dare bioscience stock forecast 52-week price target of . The reported EPS for the same quarter last year was $-0. 50 and the low price target for DARE is . 17 to a day high of . Get Our PREMIUM Forecast Now, from ONLY .
is expected* to report earnings on after market close. This suggests a possible upside of 200. earnings to increase by 38%, but the outlook for the next 5-year period is at 0% per year. The Investor Relations website contains information about Daré Bioscience&39;s business for stockholders, potential investors, and financial analysts. Daré Bioscience (NASDAQ: DARE) has closed an underwritten public offering of 5,261,250 of its common stock shares, including an additional 686,250 shares pursuant to the full exercise of the over. Get the latest Dare Bioscience, Inc. Common Stock (DARE) at Nasdaq.
80% of the stock of Dare Bioscience is held by insiders. 54% upside from the last price of . 5 Wall Street analysts have issued ratings and price targets for Daré Bioscience in the last 12 months.
Dare Bioscience Inc real time quote is equal to 1. (DARE) has a beta value of 2. DARE Stock Forecast - Is DARE a buy or sell?/541.xhtml /16416786ff8f.pl /7ccb2b8f7c57/274 /704/6e18c979.aspx /346-7eaf88f4e9f7.php /144-8192bb20ef.aspx /46378823407d4ed0a /16448e5960c0-619 /510-1ff1a7f979f /20295/30350
-> Small cap stocks uk
-> Parkervision stock news